VIVO Ventures Vii, LLC, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 13,352 shares at $11.00 ($147K) on 2015-10-07, disclosed to the SEC on 2015-10-09.
Open-market purchase of $147k ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 285 | $3K | 2.1% |
| 2 | $11.00 | 13,067 | $144K | 97.9% |
| Total | $11.00 avg | 13,352 | $147K | 100% |
| Filing → |
| CDXS | SELL | 2016-08-17 | $738K | — | Filing → |
| CDXS | SELL | 2016-08-05 | $549K | — | Filing → |
| MEIP | SELL | 2015-11-09 | $720K | — | Filing → |